Естонія - естонська - Ravimiamet

ceva sante animale - milbemütsiinoksiim+prasikvanteel - närimistablett - 25mg+250mg 2tk; 25mg+250mg 4tk; 25mg+250mg 10tk; 25mg+250mg 100tk; 25mg+250mg 24tk

Естонія - естонська - Ravimiamet

ceva sante animale - milbemütsiinoksiim+prasikvanteel - närimistablett - 12,5mg+125mg 100tk; 12,5mg+125mg 48tk; 12,5mg+125mg 10tk; 12,5mg+125mg 4tk; 12,5mg+125mg 2tk; 12,5mg+125mg 24tk

Естонія - естонська - Ravimiamet

ceva sante animale - milbemütsiinoksiim+prasikvanteel - õhukese polümeerikattega tablett - 4mg+10mg 48tk; 4mg+10mg 100tk; 4mg+10mg 2tk; 4mg+10mg 4tk; 4mg+10mg 10tk

Естонія - естонська - Ravimiamet

ceva sante animale - milbemütsiinoksiim+prasikvanteel - õhukese polümeerikattega tablett - 16mg+40mg 4tk; 16mg+40mg 2tk; 16mg+40mg 24tk; 16mg+40mg 48tk

Естонія - естонська - Ravimiamet

ceva sante animale - milbemütsiinoksiim+prasikvanteel - närimistablett - 2,5mg+25mg 10tk; 2,5mg+25mg 4tk; 2,5mg+25mg 100tk

Естонія - естонська - Ravimiamet

pekana naturheilmittel gmbh - homöopaatilised preparaadid - kõrvatilgad, lahus - 10ml 1tk

Естонія - естонська - Ravimiamet

pekana naturheilmittel gmbh - homöopaatilised preparaadid - pillid - 10g 1tk

Естонія - естонська - Ravimiamet

cenavisa s.l. - ketoprofeen - lahus joogivees manustamiseks - 300mg 1ml 500ml 1tk

Європейський Союз - естонська - EMA (European Medicines Agency)

hexal ag - alfa-epoetiin - anemia; kidney failure, chronic; cancer - antianemilised preparaadid - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. ravi aneemia ja vähendada vereülekande nõuete täiskasvanud patsientidest, keemiaravi tahkete kasvajate, pahaloomulise lümfoomi või hulgimüeloom, ja on oht, vereülekande kui hinnata patsiendi üldist seisundit (e. südame-veresoonkonna seisund, pre-olemasolevate aneemia alguses keemiaravi).

Європейський Союз - естонська - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - guanfatsiinvesinikkloriid - tähelepanupuudulikkuse häire koos hüperaktiivsusega - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv tuleb kasutada osana ulatuslikust adhd ravi programm, tavaliselt sealhulgas psühholoogilisi, pedagoogilisi ja sotsiaalseid meetmeid,.